|
|
||||||||



*
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan;
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan; and
Discovery Research Laboratory I, Minase Research Institute, Ono Pharmaceutical, Osaka, Japan
The expression and regulation of the PGE receptors, EP2
and EP4, both of which are coupled to the stimulation of
adenylate cyclase, were examined in peritoneal resident macrophages
from C3H/HeN mice. mRNA expression of EP4 but not
EP2 was found in nonstimulated cells, but the latter was
induced by medium change alone, and this induction was augmented by
LPS. mRNA expression of EP4 was down-regulated by LPS but
not by medium change. PGE2 increased the cAMP content of
both LPS-treated and nontreated cells. ONO-604, an EP4
agonist, also increased cAMP content in nonstimulated cells and in
cells treated with LPS for 3 h, but not for 6 h. Butaprost,
an EP2 agonist, was effective only in the cells treated
with LPS for 6 h. The inhibitory effects of ONO-604 on TNF-
and
IL-12 production were equipotent with PGE2 at any time
point, but the inhibitory effects of butaprost were only seen from
14 h after stimulation. PGE2 or dibutyryl cAMP alone,
but not butaprost, reduced EP4 expression, and indomethacin
reversed the LPS-induced down-regulation of EP4, indicating
that the down-regulation of EP4 is mediated by LPS-induced
PG synthesis and EP4 activation. Indeed, when we used
C3H/HeJ (LPS-hyporesponsive) macrophages, such reduction in
EP4 expression was found in the cells treated with
PGE2 alone, but not in LPS-treated cells. In contrast,
up-regulation of EP2 expression was again observed in
LPS-treated C3H/HeJ macrophages. These results suggest that
EP4 is involved mainly in the inhibition of cytokine
release, and that the gene expression of EP2 and
EP4 is differentially regulated during macrophage
activation.
This article has been cited by other articles:
![]() |
H. Kitamura, M. Ito, T. Yuasa, C. Kikuguchi, A. Hijikata, M. Takayama, Y. Kimura, R. Yokoyama, T. Kaji, and O. Ohara Genome-wide identification and characterization of transcripts translationally regulated by bacterial lipopolysaccharide in macrophage-like J774.1 cells Physiol Genomics, October 8, 2008; 33(1): 121 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Ballinger, L. L. N. Hubbard, T. R. McMillan, G. B. Toews, M. Peters-Golden, R. Paine III, and B. B. Moore Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L114 - L122. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. White, Q. Ding, B. B. Moore, M. Peters-Golden, L. B. Ware, M. A. Matthay, and M. A. Olman Prostaglandin E2 Mediates IL-1 -Related Fibroblast Mitogenic Effects in Acute Lung Injury through Differential Utilization of Prostanoid Receptors J. Immunol., January 1, 2008; 180(1): 637 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugimoto and S. Narumiya Prostaglandin E Receptors J. Biol. Chem., April 20, 2007; 282(16): 11613 - 11617. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, M. S. Chang, R. C. Hsueh, R. Taussig, K. D. Smith, M. I. Simon, and S. Choi Dual Ligand Stimulation of RAW 264.7 Cells Uncovers Feedback Mechanisms That Regulate TLR-Mediated Gene Expression J. Immunol., October 1, 2006; 177(7): 4299 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavlovic, B. Du, K. Sakamoto, K. M. F. Khan, C. Natarajan, R. M. Breyer, A. J. Dannenberg, and D. J. Falcone Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages J. Biol. Chem., February 10, 2006; 281(6): 3321 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Boven, M. Van Meurs, M. Van Zwam, A. Wierenga-Wolf, R. Q. Hintzen, R. G. Boot, J. M. Aerts, S. Amor, E. E. Nieuwenhuis, and J. D. Laman Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis Brain, February 1, 2006; 129(2): 517 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugimoto, Y. Fukada, D. Mori, S. Tanaka, H. Yamane, Y. Okuno, K. Deai, S. Tsuchiya, G. Tsujimoto, and A. Ichikawa Prostaglandin E2 Stimulates Granulocyte Colony-Stimulating Factor Production via the Prostanoid EP2 Receptor in Mouse Peritoneal Neutrophils J. Immunol., August 15, 2005; 175(4): 2606 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Hwang, S. Choi, I. D. C. Fraser, M. S. Chang, and M. I. Simon Silencing the expression of multiple G{beta}-subunits eliminates signaling mediated by all four families of G proteins PNAS, July 5, 2005; 102(27): 9493 - 9498. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, I. Take, T. Yamashita, T. Mizoguchi, T. Ninomiya, T. Hattori, S. Kurihara, H. Ozawa, N. Udagawa, and N. Takahashi Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors J. Biol. Chem., June 24, 2005; 280(25): 24035 - 24042. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Moore, M. N. Ballinger, E. S. White, M. E. Green, A. B. Herrygers, C. A. Wilke, G. B. Toews, and M. Peters-Golden Bleomycin-Induced E Prostanoid Receptor Changes Alter Fibroblast Responses to Prostaglandin E2 J. Immunol., May 1, 2005; 174(9): 5644 - 5649. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Uchiya and T. Nikai Salmonella enterica Serovar Typhimurium Infection Induces Cyclooxygenase 2 Expression in Macrophages: Involvement of Salmonella Pathogenicity Island 2 Infect. Immun., December 1, 2004; 72(12): 6860 - 6869. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Akaogi, H. Yamada, Y. Kuroda, D. C. Nacionales, W. H. Reeves, and M. Satoh Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-{alpha} and IL-6 production J. Leukoc. Biol., July 1, 2004; 76(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kubo, H. K. Takahashi, M. Takei, H. Iwagaki, T. Yoshino, N. Tanaka, S. Mori, and M. Nishibori E-Prostanoid (EP)2/EP4 Receptor-Dependent Maturation of Human Monocyte-Derived Dendritic Cells and Induction of Helper T2 Polarization J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1213 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Harizi, C. Grosset, and N. Gualde Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes J. Leukoc. Biol., June 1, 2003; 73(6): 756 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Charbeneau, P. J. Christensen, C. J. Chrisman, R. Paine III, G. B. Toews, M. Peters-Golden, and B. B. Moore Impaired synthesis of prostaglandin E2 by lung fibroblasts and alveolar epithelial cells from GM-CSF-/- mice: implications for fibroproliferation Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1103 - L1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoshino, S. Tsutsumi, W. Tomisato, H.-J. Hwang, T. Tsuchiya, and T. Mizushima Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation J. Biol. Chem., April 4, 2003; 278(15): 12752 - 12758. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Walch, E. Clavarino, and P. L. Morris Prostaglandin (PG) FP and EP1 Receptors Mediate PGF2{alpha} and PGE2 Regulation of Interleukin-1{beta} Expression in Leydig Cell Progenitors Endocrinology, April 1, 2003; 144(4): 1284 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Konger, G. A. Scott, Y. Landt, J. H. Ladenson, and A. P. Pentland Loss of the EP2 Prostaglandin E2 Receptor in Immortalized Human Keratinocytes Results in Increased Invasiveness and Decreased Paxillin Expression Am. J. Pathol., December 1, 2002; 161(6): 2065 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Walch and P. L. Morris Cyclooxygenase 2 Pathway Mediates IL-1{beta} Regulation of IL-1{alpha}, -1{beta}, and IL-6 mRNA Levels in Leydig Cell Progenitors Endocrinology, September 1, 2002; 143(9): 3276 - 3283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Scandella, Y. Men, S. Gillessen, R. Forster, and M. Groettrup Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells Blood, July 30, 2002; 100(4): 1354 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uematsu, M. Matsumoto, K. Takeda, and S. Akira Lipopolysaccharide-Dependent Prostaglandin E2 Production Is Regulated by the Glutathione-Dependent Prostaglandin E2 Synthase Gene Induced by the Toll-Like Receptor 4/MyD88/NF-IL6 Pathway J. Immunol., June 1, 2002; 168(11): 5811 - 5816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |